Most in vitro research to date examining the effects of leptin on breast cancer cell migration employed supraphysiological glucose concentrations [13, 14], and has reported that AMPK is activated by leptin treatment in breast cancer cells [13, 15]. This evidence concerns the gene LEP and breast cancer.